Research Article

Outcomes of Patients with Intestinal Failure after the Development and Implementation of a Multidisciplinary Team

Table 3

Morbidity and mortality of infants with SBS.

Pre-INFANT ()INFANT ()

Infectious complications
Patients with at least 1 septic episode [ (%)]18 (66.7)24 (85.7)0.096
Number of septic episodes per patient (mean ± SD)2.83 ± 2.662.83 ± 2.44NS
Liver disease
Presence of cholestasis [ (%)]23 (85.2)23 (82.1)0.760
Peak direct bilirubin (mean ± SD)181.6 ± 124.1116.6 ± 82.80.026
Liver failure [ (%)]00NS
Assessed for transplant [ (%)]1 (3.7)1 (3.7)NS
Transplanted [ (%)]00NS
Mortality
Overall mortality [ (%)]4 (14.8)2 (7.1)0.362
Cause of death
Respiratory failure [ (%)]2 (50) 1 (50) NS
Cardiac arrest [ (%)]1 (25)0NS
Cardiorespiratory failure [ (%)]1 (25)0NS
Septic shock [ (%)]01 (50)NS
Liver failure [ (%)]00NS

INFANT = INtestinal Failure and Advanced Nutrition Team. Results are presented as mean ± SD or (%); [ ] = of patients for that specific variable.